Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07678567 · ClinicalTrials.gov registry record
Pomegranate Dietary Supplements in AUD and ALD
A clinical trial, sponsored by University of Louisville.
- Not yet
- Registry status
- 144
- Enrollment target
NCT07678567 is a clinical trial that has not yet begun recruiting, run by University of Louisville. The registered enrollment target is 144 participants.
The verdict
NCT07678567 has not yet begun recruiting, sponsored by University of Louisville.
- NOT YET RECRUITING
- Registry status
- 144 participants
- Enrollment target
Study Summary
The goal of this project is to determine an individual's ability to generate active gut microbial metabolites called urolithins upon consumption of pomegranate dietary supplements. Recent publications have reported that urolithins are the major active metabolites responsible for the beneficial effects of eating pomegranates, berries, or walnuts. However, the production of urolithins from the parent compound ellagic acid (EA) is dependent upon the presence of certain bacteria in the human gut. In this trial, we propose to investigate variations in gut microbiota and their capacity to metabolize pomegranate dietary supplements (PDS) into active urolithins. We will measure the levels of urolithins in blood as well as inflammatory cytokines in plasma samples upon consumption of PDS.
Interventions
- DIETARY_SUPPLEMENT Pomegranate Dietary Ssupplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2027-01-01 |
| Est. Completion | 2032-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07678567
The ClinicalTrials.gov registry entry for NCT07678567 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pomegranate Dietary Ssupplement is the first listed.
NCT07678567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07678567 about?
NCT07678567 is a clinical study titled "Pomegranate Dietary Supplements in AUD and ALD". The goal of this project is to determine an individual's ability to generate active gut microbial metabolites called urolithins upon consumption of pomegranate dietary supplements. Recent publications have reported that urolithins are the major active metabolites responsible for the beneficial effec...
What is the current status of trial NCT07678567?
This trial is currently not yet recruiting. The enrollment target is 144 participants. The study started on 2027-01-01. Estimated completion is 2032-12-31.
What interventions are being tested in trial NCT07678567?
The interventions under investigation include: Pomegranate Dietary Ssupplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07678567?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.